Survival Following CDK4/6 Inhibitor Therapy for Hormone Receptor–Positive, <i>ERBB2</i>–Negative Metastatic Breast Cancer

Pier Paolo Maria Berton Giachetti, Carmen Criscitiello, Paola Zagami et al.|JAMA Network Open|2025

Cited by 11